SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-046257
Filing Date
2022-08-10
Accepted
2022-08-10 14:10:33
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_biomxinc.htm   iXBRL 10-Q 527486
2 CERTIFICATION f10q0622ex31-1_biomxinc.htm EX-31.1 10380
3 CERTIFICATION f10q0622ex31-2_biomxinc.htm EX-31.2 10749
4 CERTIFICATION f10q0622ex32_biomxinc.htm EX-32 6725
  Complete submission text file 0001213900-22-046257.txt   3284310

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phge-20220630.xsd EX-101.SCH 47071
6 XBRL CALCULATION FILE phge-20220630_cal.xml EX-101.CAL 26104
7 XBRL DEFINITION FILE phge-20220630_def.xml EX-101.DEF 165148
8 XBRL LABEL FILE phge-20220630_lab.xml EX-101.LAB 367075
9 XBRL PRESENTATION FILE phge-20220630_pre.xml EX-101.PRE 175115
45 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_biomxinc_htm.xml XML 331505
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 221151386
SIC: 2836 Biological Products, (No Diagnostic Substances)